| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.006 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.099 | 0.006 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.006 |